Full Text
PDB12 BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF ROSIGLITAZONE IN THE TREATMENT OFTYPE-2 DIABETES. THE ITALIAN NHS PERSPECTIVE

Abstract

Authors

M Novelli A Avallone V Frizzo F Bamfl

Back to Volume 8, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×